Cargando…
Computational guided approach for drug repurposing against SARS-CoV-2
Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug development. The present investigation screened 130 US FDA-approved drugs including hypertension, cardiovascular diseases, respiratory tr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923689/ http://dx.doi.org/10.2217/fvl-2020-0403 |
_version_ | 1783658946774433792 |
---|---|
author | Anand, Jigisha Ghildiyal, Tanmay Madhwal, Aakanksha Bhatt, Rishabh Verma, Devvret Rai, Nishant |
author_facet | Anand, Jigisha Ghildiyal, Tanmay Madhwal, Aakanksha Bhatt, Rishabh Verma, Devvret Rai, Nishant |
author_sort | Anand, Jigisha |
collection | PubMed |
description | Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug development. The present investigation screened 130 US FDA-approved drugs including hypertension, cardiovascular diseases, respiratory tract infections (RTI), antibiotics and antiviral drugs for their inhibitory potential against SARS-CoV-2. Materials & methods: The molecular drug targets against SARS-CoV-2 proteins were determined by the iGEMDOCK computational docking tool. The protein homology models were generated through SWISS Model workspace. The pharmacokinetics of all the ligands was determined by ADMET analysis. Results: The study identified 15 potent drugs exhibiting significant inhibitory potential against SARS-CoV-2. Conclusion: Our investigation has identified possible repurposed drug candidates to improve the current modus operandi of the treatment given to COVID-19 patients. |
format | Online Article Text |
id | pubmed-7923689 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-79236892021-03-02 Computational guided approach for drug repurposing against SARS-CoV-2 Anand, Jigisha Ghildiyal, Tanmay Madhwal, Aakanksha Bhatt, Rishabh Verma, Devvret Rai, Nishant Future Virol Research Article Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug development. The present investigation screened 130 US FDA-approved drugs including hypertension, cardiovascular diseases, respiratory tract infections (RTI), antibiotics and antiviral drugs for their inhibitory potential against SARS-CoV-2. Materials & methods: The molecular drug targets against SARS-CoV-2 proteins were determined by the iGEMDOCK computational docking tool. The protein homology models were generated through SWISS Model workspace. The pharmacokinetics of all the ligands was determined by ADMET analysis. Results: The study identified 15 potent drugs exhibiting significant inhibitory potential against SARS-CoV-2. Conclusion: Our investigation has identified possible repurposed drug candidates to improve the current modus operandi of the treatment given to COVID-19 patients. Future Medicine Ltd 2021-03-02 2021-03 /pmc/articles/PMC7923689/ http://dx.doi.org/10.2217/fvl-2020-0403 Text en © 2021 Future Medicine Ltd This work is licensed under the Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Research Article Anand, Jigisha Ghildiyal, Tanmay Madhwal, Aakanksha Bhatt, Rishabh Verma, Devvret Rai, Nishant Computational guided approach for drug repurposing against SARS-CoV-2 |
title | Computational guided approach for drug repurposing against SARS-CoV-2 |
title_full | Computational guided approach for drug repurposing against SARS-CoV-2 |
title_fullStr | Computational guided approach for drug repurposing against SARS-CoV-2 |
title_full_unstemmed | Computational guided approach for drug repurposing against SARS-CoV-2 |
title_short | Computational guided approach for drug repurposing against SARS-CoV-2 |
title_sort | computational guided approach for drug repurposing against sars-cov-2 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923689/ http://dx.doi.org/10.2217/fvl-2020-0403 |
work_keys_str_mv | AT anandjigisha computationalguidedapproachfordrugrepurposingagainstsarscov2 AT ghildiyaltanmay computationalguidedapproachfordrugrepurposingagainstsarscov2 AT madhwalaakanksha computationalguidedapproachfordrugrepurposingagainstsarscov2 AT bhattrishabh computationalguidedapproachfordrugrepurposingagainstsarscov2 AT vermadevvret computationalguidedapproachfordrugrepurposingagainstsarscov2 AT rainishant computationalguidedapproachfordrugrepurposingagainstsarscov2 |